Baldwin Wealth Partners’s Guardant Health GH Stock Holding History

Baldwin Wealth Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20	Closed	-$459	–	547
2024 Q3	$459	Sell	20 -350	-95%	-$9.91K	﹤0.01%	1033
2024 Q2	$10.7K	Hold	370	–	–	﹤0.01%	534
2024 Q1	$7.63K	Hold	370	–	–	﹤0.01%	572
2023 Q4	$10K	Hold	370	–	–	﹤0.01%	576
2023 Q3	$11K	Hold	370	–	–	﹤0.01%	569
2023 Q2	$13.2K	Hold	370	–	–	﹤0.01%	575
2023 Q1	$8.67K	Hold	370	–	–	﹤0.01%	628
2022 Q4	$10.1K	Buy	370 +20	+6%	+$915	﹤0.01%	608
2022 Q3	$19K	Hold	350	–	–	﹤0.01%	452
2022 Q2	$14K	Hold	350	–	–	﹤0.01%	503
2022 Q1	$23K	Hold	350	–	–	﹤0.01%	466
2021 Q4	$35K	Sell	350 -30	-8%	-$3.1K	﹤0.01%	391
2021 Q3	$48K	Hold	380	–	–	0.01%	353
2021 Q2	$47K	Hold	380	–	–	0.01%	364
2021 Q1	$58K	Hold	380	–	–	0.01%	328
2020 Q4	$49K	Hold	380	–	–	0.01%	321
2020 Q3	$42K	Hold	380	–	–	0.01%	312
2020 Q2	$31K	Hold	380	–	–	﹤0.01%	347
2020 Q1	$26K	Sell	380 -1,000	-72%	-$76.7K	﹤0.01%	348
2019 Q4	$108K	Hold	1,380	–	–	0.02%	231
2019 Q3	$88K	Hold	1,380	–	–	0.01%	243
2019 Q2	$119K	Buy	+1,380	New	+$105K	0.02%	231

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Baldwin Wealth Partners's GH Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of Guardant Health (GH) in Q4 2024, closing a stake of 20 shares — an estimated $459 sold.

Baldwin Wealth Partners first reported a position in GH in Q2 2019 and held it in 22 quarters. The position peaked at $119K in Q2 2019. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

Baldwin Wealth Partners reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
Baldwin Wealth Partners sold 20 Guardant Health shares in Q4 2024, an estimated $459.
Baldwin Wealth Partners first reported a position in Guardant Health in Q2 2019 and held it in 22 quarters.
Baldwin Wealth Partners's Guardant Health position peaked at $119K in Q2 2019.
298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.